Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Resistance to targeted treatment of gastroenteropancreatic neuroendocrine tumors
Matthias Beyens, Timon Vandamme, Marc Peeters, et al.
Endocrine Related Cancer (2018) Vol. 26, Iss. 3, pp. R109-R130
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

PI3K/AKT/mTOR signaling in gastric cancer: Epigenetics and beyond
Sadegh Fattahi, Fatemeh Amjadi‐Moheb, Reza Tabaripour, et al.
Life Sciences (2020) Vol. 262, pp. 118513-118513
Open Access | Times Cited: 297
Targeting PI3K/AKT/mTOR Signaling Pathway in Pancreatic Cancer: From Molecular to Clinical Aspects
Silvius Stanciu, Florentina Ioniţă‐Radu, Constantin Ștefani, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10132-10132
Open Access | Times Cited: 79
A literature review of recent advances in gastric cancer treatment: exploring the cross-talk between targeted therapies
Reza Panahizadeh, Pedram Panahi, Vahid Asghariazar, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 3
Multi-target tyrosine kinase inhibitor nanoparticle delivery systems for cancer therapy
Wenjing Xu, Chunping Ye, Qing Xin, et al.
Materials Today Bio (2022) Vol. 16, pp. 100358-100358
Open Access | Times Cited: 29
Gastroenteropancreatic neuroendocrine neoplasms: A clinical snapshot
Cornelius James Fernandez, Mayuri Agarwal, Biju Pottakkat, et al.
World Journal of Gastrointestinal Surgery (2021) Vol. 13, Iss. 3, pp. 231-255
Open Access | Times Cited: 33
mTOR Pathway in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NETs)
Sara Zanini, Serena Renzi, Francesco Giovinazzo, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 38
Treatment of advanced gastroenteropancreatic neuroendocrine neoplasia, are we on the way to personalised medicine?
Anja Rinke, Christoph J. Auernhammer, Lisa Bodei, et al.
Gut (2021) Vol. 70, Iss. 9, pp. 1768-1781
Closed Access | Times Cited: 30
Longitudinal Copy-Number Alteration Analysis in Plasma Cell-Free DNA of Neuroendocrine Neoplasms is a Novel Specific Biomarker for Diagnosis, Prognosis, and Follow-up
Gitta Boons, Timon Vandamme, Laura Mariën, et al.
Clinical Cancer Research (2021) Vol. 28, Iss. 2, pp. 338-349
Open Access | Times Cited: 28
Current treatments and future potential of surufatinib in neuroendocrine tumors (NETs)
Jianming Xu
Therapeutic Advances in Medical Oncology (2021) Vol. 13
Open Access | Times Cited: 25
Investigation of an oncolytic herpes simplex virus as a potential therapeutic agent for gastroenteropancreatic neuroendocrine neoplasms
Colin H. Quinn, Janet R. Julson, Michael H. Erwin, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Molecular Characterization and Clinical Outcomes of Pancreatic Neuroendocrine Neoplasms Harboring PAK4-NAMPT Alterations
Ibrahim Azar, Husain Yar Khan, Sahar F. Bannoura, et al.
JCO oncology advances. (2025), Iss. 2
Closed Access
PDX1 DNA Methylation Distinguishes Two Subtypes of Pancreatic Neuroendocrine Neoplasms with a Different Prognosis
Gitta Boons, Timon Vandamme, Joe Ibrahim, et al.
Cancers (2020) Vol. 12, Iss. 6, pp. 1461-1461
Open Access | Times Cited: 24
Changing biological behaviour of NETs during the evolution of the disease: progress on progression
Krystallenia Alexandraki, Ariadni Spyroglou, Stylianos Kykalos, et al.
Endocrine Related Cancer (2021) Vol. 28, Iss. 5, pp. R121-R140
Open Access | Times Cited: 19
Emerging Kinase Therapeutic Targets in Pancreatic Ductal Adenocarcinoma and Pancreatic Cancer Desmoplasia
Justin F. Creeden, Khaled Alganem, Ali Sajid Imami, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 22, pp. 8823-8823
Open Access | Times Cited: 19
Therapy Resistant Gastroenteropancreatic Neuroendocrine Tumors
Kristen McClellan, Emerson Y. Chen, Adel Kardosh, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4769-4769
Open Access | Times Cited: 12
Targeting Angiogenesis in Pancreatic Neuroendocrine Tumors: Resistance Mechanisms
Javier Pozas, María San Román, Teresa Alonso‐Gordoa, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 19, pp. 4949-4949
Open Access | Times Cited: 18
Predictive Factors for Resistant Disease with Medical/Radiologic/Liver-Directed Anti-Tumor Treatments in Patients with Advanced Pancreatic Neuroendocrine Neoplasms: Recent Advances and Controversies
Lingaku Lee, Irene Ramos-Álvarez, Robert T. Jensen
Cancers (2022) Vol. 14, Iss. 5, pp. 1250-1250
Open Access | Times Cited: 11
Advances in the Diagnosis and Therapeutic Management of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs)
Krzysztof Kaliszewski, Maksymilian Ludwig, Maria Greniuk, et al.
Cancers (2022) Vol. 14, Iss. 8, pp. 2028-2028
Open Access | Times Cited: 10
Targeting HSP90 with picropodophyllin suppresses gastric cancer tumorigenesis by disrupting the association of HSP90 and AKT
Xiaoli Li, Guoli Wang, Xiaolin Zhou, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 10, pp. 4740-4754
Closed Access | Times Cited: 5
Clinical applications of (epi)genetics in gastroenteropancreatic neuroendocrine neoplasms: Moving towards liquid biopsies
Gitta Boons, Timon Vandamme, Marc Peeters, et al.
Reviews in Endocrine and Metabolic Disorders (2019) Vol. 20, Iss. 3, pp. 333-351
Open Access | Times Cited: 14
A Neuroendocrine Biomarker Revolution From Monoanalyte to Multianalyte Biomarkers in Non-Functioning Gastro-entero-pancreatic Neuroendocrine Neoplasms
Camilla O. Hoff, João Manzi, Raphaella Ferreira, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 203, pp. 104460-104460
Closed Access | Times Cited: 1
MYC Upregulation Confers Resistance to Everolimus and Establishes Vulnerability to Cyclin-Dependent Kinase Inhibitors in Pancreatic Neuroendocrine Neoplasm Cells
Francesca Terracciano, Alessia Capone, A Montori, et al.
Neuroendocrinology (2020) Vol. 111, Iss. 8, pp. 739-751
Closed Access | Times Cited: 10
Resistant gastroenteropancreatic neuroendocrine tumors: a definition and guideline to medical and surgical management
Catherine H. Davis, Amanda M. Laird, Steven K. Libutti
Baylor University Medical Center Proceedings (2023) Vol. 37, Iss. 1, pp. 104-110
Open Access | Times Cited: 3
Circulating Angiogenic Markers in Gastroenteropancreatic Neuroendocrine Neoplasms: A Systematic Review
Irina Sandra, Irina M. Cazacu, Vlad Mihai Croitoru, et al.
Current Issues in Molecular Biology (2022) Vol. 44, Iss. 9, pp. 4001-4014
Open Access | Times Cited: 5
Reciprocal Interactions between Fibroblast and Pancreatic Neuroendocrine Tumor Cells: Putative Impact of the Tumor Microenvironment
Thomas Cuny, Peter M. van Koetsveld, Grégoire Mondielli, et al.
Cancers (2022) Vol. 14, Iss. 14, pp. 3481-3481
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top